Results 191 to 200 of about 2,307,247 (311)

Exon 7 splicing of ERα predicts poor prognosis and increases phenotypic heterogeneity in luminal a subtype breast cancer

FEBS Open Bio, EarlyView.
ERα splice variant ERα∆7 lacks the C‐terminus, and its expression may change phenotypes of breast cancers. Our results showed that ERα∆7 is found in the luminal A subtype, and elevated ERα∆7 levels are linked to improved cell survival with lower proliferation and migration.
Long Wai Tsui, Taobo Hu, Thomson Christian Husein, Wai Hei Shek, Bingrong Chen, Depeng Wang, Shu Wang, Weichuan Yu, Xiaodan Fan, Mengping Long, Toyotaka Ishibashi   +10 more
wiley   +1 more source

Remote Monitoring of Patients with Heart Failure: Characteristics of Effective Programs and Implementation Strategies

Vascular Health and Risk Management
Ioana Camelia Teleanu,1 Gabriel Cristian Bejan,1 Ioana Ruxandra Poiană,1 Anca Mîrșu-Păun,1 Silviu Ionel Dumitrescu,2,3 Ana Maria Alexandra Stănescu1,2,4,5 1“Carol Davila” University of Medicine and Pharmacy, Bucharest ...
Teleanu IC, Bejan GC, Poiană IR, Mîrșu-Păun A, Dumitrescu SI, Stănescu AMA   +5 more
doaj  

Knowledge Spillover and Innovation in Healthcare: A Comparative Study of Social Media Interaction Between Medical Technology Companies and Healthcare Professionals in Austria. [PDF]

J Mark Access Health Policy
Zilahi-Lugbauer M, Stummer H.
europepmc   +1 more source

Development of human monoclonal antibodies against TARM1 by yeast display

FEBS Open Bio, EarlyView.
Human monoclonal antibodies against TARM1 are generated by yeast display‐guided selection. These antibodies bind to soluble and cell‐surface forms of TARM1. Also, these antibodies exhibit agonistic activity in the NFAT‐GFP reporter assay, indicating that TARM1 signaling can be functionally modulated by antibodies and suggesting TARM1 as a potential ...
Rikio Yabe, Mayumi Saeki, Masaaki Hashiguchi, Sayaka Ono, Kazuhisa Aoki, Hidetaka Tanno   +5 more
wiley   +1 more source

Assessment of medical device features in health technology assessment: a review of NICE medical technology guidance. [PDF]

Int J Technol Assess Health Care
Pearson S, Andrusjaka L, Campbell M, Jensen CE, Laursen HVB, Mærkedahl A.   +5 more
europepmc   +1 more source

Screening and epitope characterization of Nidogen‐2‐specific nanobodies

FEBS Open Bio, EarlyView.
Camel immunization and phage display were employed to generate high‐affinity VHH nanobodies against Nidogen‐2. After library construction, biopanning, ELISA screening, sequencing, and recombinant expression, selected nanobodies were purified and characterized, leading to the preliminary exploration of a nanobody‐based sandwich ELISA for specific ...
Jianchuan Wen, Qianqian Cui, Zhongyun Lan, Yingjun Wang, Shuaiying Zhao, Wenxuan Feng, Yunfeng Liu, Qiting Huang, Dongna Zhang, Jianfeng Xu   +9 more
wiley   +1 more source

Contemporary Landscape of Medical Technology in Gastroenterology Between 2013 and 2023. [PDF]

Am J Gastroenterol
Hennessey MM, Xue S, Strigenz RZ, Bagley P, Shah ED.   +4 more
europepmc   +1 more source

Medical Technology: A Systematic Review on Medical Devices Utilized for Epilepsy Prediction and Management. [PDF]

Curr Neuropharmacol, 2022
Ong JS, Wong SN, Arulsamy A, Watterson JL, Shaikh MF.   +4 more
europepmc   +1 more source

Quantitative proteomic analysis reveals different characteristics of bladder cancer cells after exposure to bisphenol A

FEBS Open Bio, EarlyView.
Bisphenol A (BPA), a common chemical in plastics, exerts dual effects on bladder cancer cells: low doses promote growth and migration, while high doses suppress growth and migration. Multi‐omics and bioinformatics reveal BPA acts via MAPK and inflammatory pathways.
Shaomin Niu, Lanlan Li, Wenjuan Jia, Hanzhong Feng, Xiaoquan Yu, Youli Zhao, Fengzhi Yuan, Hui Ding, Junqiang Tian, Yong‐Xing He, Zhiping Wang   +10 more
wiley   +1 more source

Apple Vision Pro: A Paradigm Shift in Medical Technology. [PDF]

Cureus
Shanbhag NM, Bin Sumaida A, Al Shamisi K, Balaraj K.   +3 more
europepmc   +1 more source